NO20023190D0 - Oral mucosal dosage forms for apomorphine - Google Patents

Oral mucosal dosage forms for apomorphine

Info

Publication number: NO20023190D0
Authority: NO; Norway
Prior art keywords: apomorphine; dosage forms; oral mucosal; mucosal dosage; oral
Prior art date: 1999-12-30

Application number

NO20023190A

Other languages

Norwegian (no)

Other versions

NO20023190L (en

Inventor

Paul Edward Stach

Craig William Davis

Raymundo Acurantes Sison

Robert Kenneth Mansfield

John Daniel Bollinger

Pramod Kumar Gupta

Original Assignee

Tap Holdings Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-12-30

Filing date

2002-07-01

Publication date

2002-07-01

2002-07-01 Application filed by Tap Holdings Inc filed Critical Tap Holdings Inc

2002-07-01 Publication of NO20023190D0 publication Critical patent/NO20023190D0/en

2002-08-29 Publication of NO20023190L publication Critical patent/NO20023190L/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Neurosurgery (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Physiology (AREA)
Nutrition Science (AREA)
Psychology (AREA)
Zoology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Other In-Based Heterocyclic Compounds (AREA)

NO20023190A 1999-12-30 2002-07-01 Oral mucosal dosage forms for apomorphine NO20023190L (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US47584499A	1999-12-30	1999-12-30
PCT/US2000/034548 WO2001049292A1 (en)	1999-12-30	2000-12-19	Oral mucosal dosage forms of apomorphine

Publications (2)

Publication Number	Publication Date
NO20023190D0 true NO20023190D0 (en)	2002-07-01
NO20023190L NO20023190L (en)	2002-08-29

Family

ID=23889387

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20023190A NO20023190L (en)	1999-12-30	2002-07-01	Oral mucosal dosage forms for apomorphine

Country Status (14)

Country	Link
EP (1)	EP1242088A1 (en)
JP (1)	JP2004501065A (en)
CN (1)	CN1414853A (en)
AU (1)	AU2440901A (en)
BR (1)	BR0012822A (en)
CA (1)	CA2394297A1 (en)
CZ (1)	CZ20022245A3 (en)
HK (1)	HK1051315A1 (en)
HU (1)	HUP0400495A3 (en)
IL (1)	IL150034A0 (en)
MX (1)	MXPA02006034A (en)
NO (1)	NO20023190L (en)
PL (1)	PL366204A1 (en)
WO (1)	WO2001049292A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE0202365D0 (en)	2002-08-05	2002-08-05	Pharmacia Ab	New formulation and use thereof
AU2004206199B2 (en) *	2003-01-24	2009-03-12	Magle Holding Ab	A composition material for transmucosal delivery
SE0302947D0 (en)	2003-01-24	2003-11-07	Magle Ab	A composition material for transmucosal delivery
US8263121B2 (en)	2004-04-14	2012-09-11	Takeda Pharmaceutical Company Limited	Solid pharmaceutical preparation
GB0509317D0 (en) *	2005-05-06	2005-06-15	Clarke Anthony	Pharmaceutical formulation of apomorphine
CA2765291C (en) *	2009-06-12	2016-03-08	Adagio Pharmaceuticals Ltd.	Sublingual apomorphine
US20220249465A1 (en) *	2019-05-31	2022-08-11	Primo Pharmatech Llc	Unit dosage form for transmucosal drug delivery of an active pharmaceutical ingredient

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE241984T1 (en) *	1993-03-26	2003-06-15	Franciscus Wilhelmus He Merkus	PHARMACEUTICAL COMPOSITIONS FOR INTRANASAL ADMINISTRATION OF APOMORPHINE
GB9517062D0 (en) *	1995-08-18	1995-10-25	Scherer Ltd R P	Pharmaceutical compositions

2000
- 2000-12-19 CN CN00818098A patent/CN1414853A/en active Pending
- 2000-12-19 MX MXPA02006034A patent/MXPA02006034A/en unknown
- 2000-12-19 CZ CZ20022245A patent/CZ20022245A3/en unknown
- 2000-12-19 CA CA002394297A patent/CA2394297A1/en not_active Abandoned
- 2000-12-19 AU AU24409/01A patent/AU2440901A/en not_active Abandoned
- 2000-12-19 HK HK03101912.0A patent/HK1051315A1/en unknown
- 2000-12-19 IL IL15003400A patent/IL150034A0/en unknown
- 2000-12-19 BR BR0012822-8A patent/BR0012822A/en not_active IP Right Cessation
- 2000-12-19 WO PCT/US2000/034548 patent/WO2001049292A1/en not_active Ceased
- 2000-12-19 JP JP2001549660A patent/JP2004501065A/en not_active Withdrawn
- 2000-12-19 EP EP00988174A patent/EP1242088A1/en not_active Withdrawn
- 2000-12-19 HU HU0400495A patent/HUP0400495A3/en unknown
- 2000-12-19 PL PL00366204A patent/PL366204A1/en not_active Application Discontinuation
2002
- 2002-07-01 NO NO20023190A patent/NO20023190L/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
BR0012822A (en)	2004-03-09
HUP0400495A2 (en)	2004-06-28
WO2001049292A1 (en)	2001-07-12
HUP0400495A3 (en)	2007-05-02
JP2004501065A (en)	2004-01-15
AU2440901A (en)	2001-07-16
IL150034A0 (en)	2002-12-01
NO20023190L (en)	2002-08-29
EP1242088A1 (en)	2002-09-25
CZ20022245A3 (en)	2002-10-16
CA2394297A1 (en)	2001-07-12
PL366204A1 (en)	2005-01-24
MXPA02006034A (en)	2004-08-23
HK1051315A1 (en)	2003-08-01
CN1414853A (en)	2003-04-30

Publication	Publication Date	Title
NL300328I2 (en)	2008-07-01	Composition oral prolonged-release dose
ATE392890T1 (en)	2008-05-15	HYDROGEL-CONTROLLED DOSAGE FORM
EP1196147A4 (en)	2005-04-20	ORAL LIQUID COMPOSITIONS
ATE289796T1 (en)	2005-03-15	ORAL COMPOSITION
ATE409014T1 (en)	2008-10-15	ORAL TREATMENT DEVICE
DE60031024D1 (en)	2006-11-16	Fluororubber compositions
IS6686A (en)	2003-01-16	Hydrogel-powered dosage form
DE60028268D1 (en)	2006-07-06	Fluororubber compositions
EE200100502A (en)	2002-12-16	Compounds
DE60007530D1 (en)	2004-02-05	ORAL EFFECTIVE ANDROGENE
ID29149A (en)	2001-08-02	ADJUVAN COMPOSITION
DE10196204T1 (en)	2003-04-24	Oral devices
NO20020030L (en)	2002-03-05	Crystalline 1-methylcarbapenem compounds
NO20041383L (en)	2004-06-01	Flash melt oral dosage formulation
NO20014926D0 (en)	2001-10-10	Pharmaceutical compounds
DE60326998D1 (en)	2009-05-14	ORAL PREPARATION
NO20002439D0 (en)	2000-05-11	New oral dosage forms for carvediol
NO20013769D0 (en)	2001-08-01	Calcilitic compounds
ID30397A (en)	2001-11-29	PRUKALOPRIDA ORAL SOLUTION
NO20023190L (en)	2002-08-29	Oral mucosal dosage forms for apomorphine
DK1216032T3 (en)	2008-06-02	Controlled-release oral formulations
NO20030416D0 (en)	2003-01-27	Crystalline therapeutic compound
ID29984A (en)	2001-10-25	BIS-STIRILBIFENIL COMPOUNDS
ES1047845Y (en)	2001-10-01	ALVEOLAR FEEDER
SE9901967D0 (en)	1999-05-31	New solid dosage formulation

Legal Events

Date	Code	Title	Description
2006-06-06	FC2A	Withdrawal, rejection or dismissal of laid open patent application